Compton Capital Management Inc Gilead Sciences, Inc. Transaction History

Compton Capital Management Inc

$4.32 Billion
Q2 2023

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $726,172 - $827,335	-9,393 Reduced 58.28%	6,724 $557,000
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $189,452 - $271,988	-3,040 Reduced 15.87%	16,117 $1.38 Million
Q3 2022 Nov 08, 2022	SELL	$59.54 - $68.01 $77,044 - $88,004	-1,294 Reduced 6.33%	19,157 $1.18 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $123,001 - $138,536	-2,131 Reduced 9.44%	20,451 $1.26 Million
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $22,059 - $25,037	340 Added 1.53%	22,582 $1.64 Million
Q3 2021 Nov 10, 2021	SELL	$67.69 - $73.03 $408,712 - $440,955	-6,038 Reduced 21.35%	22,242 $1.55 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $65,818 - $71,915	1,037 Added 3.81%	28,280 $1.95 Million
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $9,000 - $10,268	-150 Reduced 0.55%	27,243 $1.76 Million
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $69,396 - $79,073	1,225 Added 4.68%	27,393 $1.6 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $71,725 - $90,182	-1,155 Reduced 4.23%	26,168 $1.65 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $1.86 Million - $2.16 Million	-25,660 Reduced 48.43%	27,323 $2.1 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $98,642 - $126,346	-1,575 Reduced 2.89%	52,983 $3.96 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $147,579 - $162,333	-2,395 Reduced 4.21%	54,558 $3.55 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $3,093 - $3,469	50 Added 0.09%	56,953 $3.85 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $90,204 - $117,710	-1,490 Reduced 2.55%	56,903 $3.56 Million
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $91,951 - $101,806	-1,290 Reduced 2.16%	58,393 $4.51 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $35,489 - $41,396	-547 Reduced 0.91%	59,683 $4.23 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $51,716 - $63,048	-710 Reduced 1.17%	60,230 $4.54 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $101,033 - $118,598	-1,420 Reduced 2.28%	60,940 $4.37 Million
Q3 2017 Nov 14, 2017	SELL	$72.11 - $85.47 $269,330 - $319,230	-3,735 Reduced 5.65%	62,360 $5.05 Million
Q2 2017 Aug 14, 2017	BUY	N/A	66,095	66,095 $4.68 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Account